Succession of microbial consortia in the developing infant gut microbiome
Evidence comparison: BPC-157 has a broader preclinical evidence base spanning gastrointestinal, musculoskeletal, neurological, and cardiovascular injury models
[1] Women who discover a pregnancy while on a GLP-1 agent should stop the medication immediately and contact their prescriber, then report to the Novo Nordisk pregnancy exposure registry at 1-800-727-6500
What to know about new study showing weight loss drugs can lower cancer risk GLP-1 medications such as Ozempic and Wegovy have exploded in popularity for their weight loss benefits and now new research is showing the medications may help with another condition, cancer
We will look at different delivery formats, the importance of ingredient purity, and how to choose a formula that your body can actually use
Exendin-4 is effective against metabolic disorders induced by intrauterine and postnatal overnutrition in rodents
